{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:24:04Z","timestamp":1770434644018,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,9,24]],"date-time":"2011-09-24T00:00:00Z","timestamp":1316822400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s12013-011-9295-0","type":"journal-article","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T15:35:10Z","timestamp":1316792110000},"page":"365-372","source":"Crossref","is-referenced-by-count":23,"title":["Elevated Levels of Oxidized Low-Density Lipoprotein Correlate Positively with C-Reactive Protein in Patients with Acute Coronary Syndrome"],"prefix":"10.1007","volume":"62","author":[{"given":"Ya-chen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-jing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-tian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,24]]},"reference":[{"key":"9295_CR1","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/MJT.0b013e3181727d06","volume":"17","author":"PD Patel","year":"2010","unstructured":"Patel, P. D., & Arora, R. R. (2010). Practical implications of ACC\/AHA 2007 Guidelines for the Management of Unstable Angina\/Non-ST Elevation Myocardial Infarction. American Journal of Therapeutics, 17, e24\u2013e40.","journal-title":"American Journal of Therapeutics"},{"key":"9295_CR2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.V102413","volume":"10","author":"JS Cameron","year":"1999","unstructured":"Cameron, J. S. (1999). Lupus nephritis. Journal of the American Society of Nephrology, 10, 413\u2013424.","journal-title":"Journal of the American Society of Nephrology"},{"key":"9295_CR3","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1056\/NEJM199705013361802","volume":"336","author":"AP Burke","year":"1997","unstructured":"Burke, A. P., Farb, A., & Malcom, G. T. (1997). Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. The New England Journal of Medicine, 336, 1276\u20131282.","journal-title":"The New England Journal of Medicine"},{"key":"9295_CR4","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.CIR.90.4.2126","volume":"90","author":"V Fuster","year":"1994","unstructured":"Fuster, V., & Lewis, A. (1994). Conner memorial lecture. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology. Circulation, 90, 2126\u20132146.","journal-title":"Circulation"},{"key":"9295_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross, R. (1999). Atherosclerosis: An inflammatory disease. The New England Journal of Medicine, 340, 115\u2013126.","journal-title":"The New England Journal of Medicine"},{"key":"9295_CR6","doi-asserted-by":"crossref","first-page":"SII5","DOI":"10.1016\/S0140-6736(99)90234-9","volume":"353","author":"V Fuster","year":"1999","unstructured":"Fuster, V., Fayad, Z. A., & Badimon, J. J. (1999). Acute coronary syndromes: Biology. Lancet, 353, SII5\u2013SII9.","journal-title":"Lancet"},{"key":"9295_CR7","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1001\/jama.286.17.2107","volume":"286","author":"E Lindmark","year":"2001","unstructured":"Lindmark, E., Diderholm, E., Wallentin, L., & Siegbahn, A. (2001). Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: Effects of an early invasive or noninvasive strategy. The Journal of the American Medical Association, 286, 2107\u20132113.","journal-title":"The Journal of the American Medical Association"},{"key":"9295_CR8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1050-1738(01)00100-1","volume":"11","author":"GK Marathe","year":"2001","unstructured":"Marathe, G. K., Prescott, S. M., Zimmerman, G. A., & McIntyre, T. M. (2001). Oxidized LDL contains inflammatory PAF-like phospholipids. Trends in Cardiovascular Medicine, 11, 139\u2013142.","journal-title":"Trends in Cardiovascular Medicine"},{"key":"9295_CR9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0735-1097(00)01199-2","volume":"37","author":"T Inoue","year":"2001","unstructured":"Inoue, T., Uchida, T., Kamishirado, H., Takaya-nagi, K., Hayashi, T., & Morooka, S. (2001). Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. Journal of the American College of Cardiology, 37, 775\u2013779.","journal-title":"Journal of the American College of Cardiology"},{"key":"9295_CR10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.98.15.1487","volume":"98","author":"P Holvoet","year":"1998","unstructured":"Holvoet, P., Vanhaecke, J., Janssens, S., Van de Werf, F., & Collen, D. (1998). Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation, 98, 1487\u20131494.","journal-title":"Circulation"},{"key":"9295_CR11","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/01.ATV.20.10.2243","volume":"20","author":"S Toshima","year":"2000","unstructured":"Toshima, S., Hasegawa, A., Kurabayashi, M., et al. (2000). Circulating oxidized low density lipoprotein levels: A biochemical risk marker for coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 2243\u20132247.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"9295_CR12","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI115499","volume":"88","author":"JL Witztum","year":"1991","unstructured":"Witztum, J. L., & Steinberg, D. (1991). Role of oxidized low density lipoprotein in atherogenesis. Journal of Clinical Investigation, 88, 1785\u20131792.","journal-title":"Journal of Clinical Investigation"},{"key":"9295_CR13","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1172\/JCI114271","volume":"84","author":"S Yl\u00e4-Herttuala","year":"1989","unstructured":"Yl\u00e4-Herttuala, S., Palinski, W., Rosenfeld, M. E., et al. (1989). Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. Journal of Clinical Investigation, 84, 1086\u20131095.","journal-title":"Journal of Clinical Investigation"},{"key":"9295_CR14","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1073\/pnas.86.4.1372","volume":"86","author":"W Palinski","year":"1989","unstructured":"Palinski, W., Rosenfeld, M. E., Yl\u00e4-Herttuala, S., et al. (1989). Low density lipoprotein undergoes oxidative modification in vivo. Proceedings of the National Academy of Sciences of the United States of America, 86, 1372\u20131376.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9295_CR15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(92)90926-T","volume":"339","author":"JT Salonen","year":"1992","unstructured":"Salonen, J. T., Yl\u00e4-Herttuala, S., Yamamoto, R., et al. (1992). Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet, 339, 883\u2013887.","journal-title":"Lancet"},{"key":"9295_CR16","doi-asserted-by":"crossref","unstructured":"Haverkate, F., Thompson, S. G., Pyke, S. D. M., Gallimore, J. R., Pepys, M. B. & for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. (1997). Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet, 349, 462\u2013466.","DOI":"10.1016\/S0140-6736(96)07591-5"},{"key":"9295_CR17","first-page":"T19","volume":"Suppl1","author":"W Koenig","year":"1999","unstructured":"Koenig, W. (1999). Atherosclerosis involves more than just lipids: Focus on inflammation. European Heart Journal, Suppl1, T19\u2013T26.","journal-title":"European Heart Journal"},{"issue":"21 Suppl 1","key":"9295_CR18","first-page":"II2","volume":"109","author":"JT Willerson","year":"2004","unstructured":"Willerson, J. T., & Ridker, P. M. (2004). Inflammation as a cardiovascular risk factor. Circulation, 109(21 Suppl 1), II2\u2013II10.","journal-title":"Circulation"},{"key":"9295_CR19","doi-asserted-by":"crossref","unstructured":"Ridker, P. M., Fonseca, F. A., Genest, J., et al. & JUPITER Trial Study Group. (2007). Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. American Journal of Cardiology, 100, 1659\u20131664.","DOI":"10.1016\/j.amjcard.2007.09.072"},{"key":"9295_CR20","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/oxfordjournals.eurheartj.a015068","volume":"17","author":"KO Pietil","year":"1996","unstructured":"Pietil, K. O., Harmoinen, A. P., Jokiniitty, J., & Pasternack, A. I. (1996). Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24\u00a0months of follow-up in patients under thrombolytic treatment. European Heart Journal, 17, 1345\u20131349.","journal-title":"European Heart Journal"},{"key":"9295_CR21","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/clinchem\/46.10.1597","volume":"46","author":"RJ Winter De","year":"2000","unstructured":"De Winter, R. J., Fischer, J., Bholasingh, R., et al. (2000). C-reactive protein and cardiac troponin T in risk stratification: Differences in optimal timing of tests early after the onset of chest pain. Clinical Chemistry, 46, 1597\u20131603.","journal-title":"Clinical Chemistry"},{"key":"9295_CR22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/clc.4960240718","volume":"24","author":"GV Moukarbel","year":"2001","unstructured":"Moukarbel, G. V., Arnaout, M. S., & Alam, S. E. (2001). C-reactive protein is a marker for a complex culprit lesion anatomy in unstable angina. Clinical Cardiology, 24, 506\u2013510.","journal-title":"Clinical Cardiology"},{"key":"9295_CR23","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1194\/jlr.M600414-JLR200","volume":"48","author":"M Tabuchi","year":"2007","unstructured":"Tabuchi, M., Inoue, K., Usui-Kataoka, H., et al. (2007). The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis. Journal of Lipid Research, 48, 768\u2013781.","journal-title":"Journal of Lipid Research"},{"key":"9295_CR24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00041433-199810000-00008","volume":"9","author":"JL Witztum","year":"1998","unstructured":"Witztum, J. L., & Berliner, J. A. (1998). Oxidized phospholipids and isoprostanes in atherosclerosis. Current Opinion in Lipidology, 9, 441\u2013448.","journal-title":"Current Opinion in Lipidology"},{"key":"9295_CR25","doi-asserted-by":"crossref","unstructured":"Chobanian, A. V., Bakris, G. L., Black H. R., et al. & the National High Blood Pressure Education Program Coordinating Committee. (2003). The Seventh report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (The JNC 7 Report). The Journal of the American Medical Association, 289, 2560\u20132571.","DOI":"10.1001\/jama.289.19.2560"},{"key":"9295_CR26","first-page":"7","volume":"727","author":"WHO Study Group","year":"1985","unstructured":"WHO Study Group. (1985). Diabetes mellitus. World Health Organization Technical Report Series, 727, 7\u201398.","journal-title":"World Health Organization Technical Report Series"},{"key":"9295_CR27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/01.CIR.75.2.452","volume":"75","author":"GB Mancini","year":"1987","unstructured":"Mancini, G. B., Simon, S. B., McGillem, M. J., et al. (1987). Automated quantitative coronary arteriography: Morphologic and physiologic validation in vivo of a rapid digital angiographic method. Circulation, 75, 452\u2013460.","journal-title":"Circulation"},{"key":"9295_CR28","unstructured":"National Heart, Lung, and Blood Institute Coronary Artery Surgery Study. (1981). A multicenter comparison of the effects of randomized medical and surgical treatment of mildly symptomatic patients with coronary artery disease and a registry of consecutive patients undergoing coronary angiography. Circulation, 63, I1\u2013I81."},{"key":"9295_CR29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-2275(20)37634-3","volume":"37","author":"H Itabe","year":"1996","unstructured":"Itabe, H., Yamamoto, H., Imanaka, T., et al. (1996). Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. Journal of Lipid Research, 37, 45\u201353.","journal-title":"Journal of Lipid Research"},{"key":"9295_CR30","first-page":"1055","volume":"41","author":"D Li","year":"2003","unstructured":"Li, D., William, V., & Liu, L. (2003). Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. Journal of the American College of Cardiology, 41, 1055\u20131084.","journal-title":"Journal of the American College of Cardiology"},{"key":"9295_CR31","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.20060218","volume":"203","author":"JW Heinecke","year":"2006","unstructured":"Heinecke, J. W. (2006). Lipoprotein oxidation in cardiovascular disease: Chief culprit or innocent bystander. Journal of Experimental Medicine, 203, 813\u2013816.","journal-title":"Journal of Experimental Medicine"},{"key":"9295_CR32","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.103.15.1955","volume":"103","author":"S Ehara","year":"2001","unstructured":"Ehara, S., Ueda, M., & Naruko, T. (2001). Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation, 103, 1955\u20131960.","journal-title":"Circulation"},{"key":"9295_CR33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0735-1097(02)02769-9","volume":"41","author":"S Tsimikas","year":"2003","unstructured":"Tsimikas, S., Bergmark, C., Beyer, R. W., et al. (2003). Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndrome. Journal of the American College of Cardiology, 41, 360\u2013370.","journal-title":"Journal of the American College of Cardiology"},{"key":"9295_CR34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.mol.0000245255.40634.b5","volume":"17","author":"AE Fraley","year":"2006","unstructured":"Fraley, A. E., & Tsinikas, S. (2006). Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Current Opinion in Lipidology, 17, 502\u2013509.","journal-title":"Current Opinion in Lipidology"},{"key":"9295_CR35","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","volume":"102","author":"V Pasceri","year":"2000","unstructured":"Pasceri, V., Willerson, J. T., & Yeh, E. T. (2000). Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation, 102, 2165\u20132168.","journal-title":"Circulation"},{"key":"9295_CR36","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1161\/01.ATV.18.9.1386","volume":"18","author":"J Torzewski","year":"1998","unstructured":"Torzewski, J., Torzewski, M., Bowyer, D. E., et al. (1998). C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 1386\u20131392.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-011-9295-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12013-011-9295-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-011-9295-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T02:25:31Z","timestamp":1638843931000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12013-011-9295-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,24]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["9295"],"URL":"https:\/\/doi.org\/10.1007\/s12013-011-9295-0","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,24]]}}}